MEK inhibitors against MET-amplified non-small cell lung cancer

Several receptor tyrosine kinases (RTKs) including EGFR, ALK, and MET have been identified as therapeutic targets in non-small cell lung cancer (NSCLC). Among the downstream pathways of RTKs, the MAPK pathway is particularly important for cancer cell proliferation, differentiation, and survival. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiba, Masato, Togashi, Yosuke, Tomida, Shuta, Mizuuchi, Hiroshi, Nakamura, Yu, Banno, Eri, Hayashi, Hidetoshi, Terashima, Masato, De Velasco, Marco A., Sakai, Kazuko, Fujita, Yoshihiko, Mitsudomi, Tetsuya, Nishio, Kazuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118002/
https://www.ncbi.nlm.nih.gov/pubmed/27748834
http://dx.doi.org/10.3892/ijo.2016.3736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118002/
https://www.ncbi.nlm.nih.gov/pubmed/27748834
http://dx.doi.org/10.3892/ijo.2016.3736

Ejemplares similares